Quince Therapeutics (NASDAQ:QNCX) Lowered to “Strong Sell” Rating by Wall Street Zen

Chronological Source Flow
Back

AI Fusion Summary

Wall Street Zen downgraded Quince Therapeutics, Cogent Communications, Cabaletta Bio, and Byrna Technologies to sell or strong sell. Quince saw hold market perform cuts; Cogent had mixed target changes; Cabaletta had buy sell ratings; Byrna received upgrades, price objective adjustments.
18/04 08:05 defenseworld.net
10 Πηγές
18/04 08:07 defenseworld.net
18/04 08:07 defenseworld.net
18/04 08:07 defenseworld.net
18/04 08:17 defenseworld.net
18/04 08:17 defenseworld.net
18/04 08:17 defenseworld.net
18/04 08:33 defenseworld.net
18/04 08:56 defenseworld.net
18/04 08:56 defenseworld.net
Comments
Loading...
0